Karim Gariani
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine 8
- Aging top 2%
- Physiology top 1%
- Diet and metabolism studies 9
- Rehabilitation top 1%
- Wound Healing and Treatments 14
-
- Diabetic Foot Ulcer Assessment and Management 18
- Diabetes Treatment and Management 13
- Diabetes Management and Research 9
-
- Liver Disease Diagnosis and Treatment 12
-
- Streptococcal Infections and Treatments 9
- Co-authors
- Dongryeol RyuFrançois R. JornayvazJohan AuwerxKristina SchoonjansKeir J. MenziesHongbo ZhangYibo WuXu Wang
- Partner nations
- SwitzerlandUnited StatesSouth Korea
In The Last Decade
Karim Gariani
90 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Geriatrics and Gerontology 518
- Aging 160
- Physiology 249
- Rehabilitation 347
- Endocrinology, Diabetes and Metabolism 764
Countries citing papers authored by Karim Gariani
This map shows the geographic impact of Karim Gariani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Gariani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Gariani more than expected).
Fields of papers citing papers by Karim Gariani
This network shows the impact of papers produced by Karim Gariani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Gariani. The network helps show where Karim Gariani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karim Gariani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 12 | |
| 7 | Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and managementbreakdown → | 2023 | 115 |
| 8 | 2023 | 13 | |
| 9 | Mitochondria-associated programmed cell death as a therapeutic target for age-related diseasebreakdown → | 2023 | 159 |
| 10 | 2023 | 2 | |
| 11 | 2023 | 39 | |
| 12 | 2022 | 1 | |
| 13 | Plantar Fasciitis in Diabetic Foot Patients: Risk Factors, Pathophysiology, Diagnosis, and Management | 2020 | 1 |
| 14 | 2020 | 14 | |
| 15 | 2019 | 22 | |
| 16 | NAD + repletion improves mitochondrial and stem cell function and enhances life span in micebreakdown → | 2016 | 904 |
| 17 | 2016 | 129 | |
| 18 | 2015 | 9 | |
| 19 | 2012 | 1 | |
| 20 | Diabète et cancer: une association pernicieuse | 2010 | 2 |
About Karim Gariani
Karim Gariani is a scholar working on Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology and Rehabilitation, having authored 101 papers that have together received 3.4k indexed citations. Recurring topics across this work include Diabetic Foot Ulcer Assessment and Management (18 papers), Wound Healing and Treatments (14 papers), Diabetes Treatment and Management (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Diet and metabolism studies (9 papers), Diabetes Management and Research (9 papers), Streptococcal Infections and Treatments (9 papers) and Sirtuins and Resveratrol in Medicine (8 papers). The work is most often cited by research in Geriatrics and Gerontology (518 citations), Aging (160 citations) and Physiology (249 citations). Karim Gariani has collaborated with scholars based in Switzerland, United States and South Korea. Frequent co-authors include Dongryeol Ryu, François R. Jornayvaz, Johan Auwerx, Kristina Schoonjans, Keir J. Menzies, Hongbo Zhang, Yibo Wu, Xu Wang, Eduardo R. Ropelle and Davide D’Amico. Their work appears in journals such as Nature, Science and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.